FindTrial
Sign In

Comparison of analgesic efficacy of simple Bupivacaine with that of a combination of Bupivacaine and Dexamethasone in Erector spinae plane block for post operative analgesia in breast carcinoma patients undergoing Modified Radical Mastectomy surgery.

COMPARISON OF BUPIVACAINE VERSUS BUPIVACAINE PLUS DEXAMETHASONE AS ADJUVANT IN ERECTOR SPINAE PLANE BLOCK FOR POST OPERATIVE ANALGESIA IN MODIFIED RADICAL MASTECTOMY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046609
Enrollment
60
Registered
2022-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 0.25% Bupivacaine with added 8mg Dexamethasone- 20ml vol: Given as single shot in Erector spinae plane block in patients undergoing MRM breast surgery just prior extubation Control Inte

Sponsors

Command Hospital kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA- I&II cases of carcinoma breast planned for MRM

Exclusion criteria

Exclusion criteria: 1 BMI > 30 2 Distant metastatic malignancy. 3 Coagulopathy. 4 known hypersensitivity to Bupivacaine and dexamethasone. 5 known psychiatric illness. - Spinal deformities. - Skin infection at site of injection. - Refusal to consent

Design outcomes

Primary

MeasureTime frame
Time to first analgesia demandTimepoint: 24hrs—

Secondary

MeasureTime frame
Cumulative analgesia usedTimepoint: 24hrs;Numerical pain scale scoreTimepoint: 24hrs;Post operative nausea vomitingTimepoint: 24hrs—

Countries

India

Contacts

Public ContactArnab Halder

Command Hospital, Kolkata

drjsbhatia@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026